2016年医疗领域十大趋势预测(Frost & Sullivan)

2015-12-25 Frost & Sullivan Frost & Sullivan

2015已接近尾声,Frost & Sullivan 的专家和意见领袖们就2016年医疗领域的发展趋势做出了以下十大预测:1.新一代可穿戴设备的市场销售额将达到六十亿美元新一代可穿戴设备的传感、捕捉和分析功能将得到强化,因此也将更适于临床使用。目前,在售的可穿戴式医疗设备(如Vital Connect和Proteus Digital Health公司开发的一些设备)主要利用的是监

2015已接近尾声,Frost & Sullivan 的专家和意见领袖们就2016年医疗领域的发展趋势做出了以下十大预测:


1.新一代可穿戴设备的市场销售额将达到六十亿美元

新一代可穿戴设备的传感、捕捉和分析功能将得到强化,因此也将更适于临床使用。目前,在售的可穿戴式医疗设备(如Vital Connect和Proteus Digital Health公司开发的一些设备)主要利用的是监测技术。随着科技的不断发展,接下来,那些可在治疗方面提供支持的设备将继续获得市场支持,如Neurometrix公司开发的Quell。

Frost & Sullivan最近就消费者行为和数字医疗所做的一项研究显示,目前,大约有24%的消费者使用移动app来追踪个人健康,16%的消费者使用可穿戴式传感器,而使用个人电子病历的消费者大约达到了29%。据预测,在不久的将来,这一趋势还会继续,使用可穿戴设备的消费者占比可能会升至47%。

2. 零售医疗将获取主流地位,诊所覆盖面将扩大至35%

2015年,在零售医疗业的投资中,有很大一部分是用于扩大诊所的覆盖面、获取新的医疗工具以及和医疗公司建立商业合作伙伴关系。据此推断,2016年,为了满足自己发展成为初级医疗服务最前沿的野心,零售商们将大展手脚,充分实施各自的发展扩张战略。

3. 新开发银行将加大在医疗领域的投资力度,这将改变多国的发展动力

新开发银行(前身为金砖银行)的成立资本高达一千亿美元,它是由美国和欧洲大股东所控制的其他世界银行组织的强劲对手。该银行致力于提升发展中国家民众的生活水平,它的主要计划包括提供资金为那些医疗条件薄弱的群体建立医疗基础设施。

4. 私人医疗保险业务在印度迅速扩张,将开辟新的市场

截止到2014年3月,印度医疗保险的覆盖率只有17%。因此,民众看病的花费很高,负担很重,自费的部分超过75%。新一届印度政府采取优先发展医疗的战略,并推行了国家医保计划,该计划不仅为民众提供免费的药物和诊断服务,同时还可以帮助个体享受到廉价保险。

5. 人口健康将拉动超过500亿美元的医疗企业并购额

据估计,和人口健康管理相关的公司长期策略将成为公司重组、并购、抽资脱离、研发投入等决策的驱动因素。

对于人口健康工具的要求使得公司不得不从另一个视角考虑他们的收购策略,这将造成的影响是,临近市场或互补市场的公司之间的业务量将增大。

6. 医护地点检测(POC)变得更加及时,并且费用下降,这可能会催生新的诊断模式

新型医护地点检测平台被赋予了新的功用,例如分子POC、联通特性、生物传感器以及微流控系统。倘若将这些新型平台应用于实际操作,实现其商业化,医师的周转时间将得到大幅提升(从5分钟延长至15分钟),检测服务可以在事发地点进行,而这在以前是无法实现的。

7. 在美国,免费预防保健服务的覆盖率将超过90%

为了降低慢性疾病晚期患者的医疗费用和负担,从付款人、雇主到政府都将提供一系列的技术和福利,为民众充分享受到预防保健创造便利。与此同时,消费者的参与必将对预防保健服务行业产生影响,这一点也是我们所期待看到的。

8. 医疗行业的物联网策略将为初创企业吸引100亿美元的风投


众多处于发展阶段初期的公司计划将他们在其他行业打磨形成的物联网专业知识引入医疗行业,此举将使医疗行业的创业环境得到恢复。这些公司关注分裂性的商业模式,他们期待推动摒弃过时的医护服务提供形式,并采用那些充分利用新技术和新工具的医护服务提供方式。

9. 医院将投入大量资金用于整修和改造过时设备,以阻挡医院发展颓势

众多医院倒闭或合并的发展颓势使得他们不得不重新思考,从医院整体布局到资源合理利用,思考范围涵盖了方方面面。为了使自身的发展能够适应注重高效率和患者满意度的医护服务提供新形式,全国范围内的众多医院都在推行改造计划,例如达拉斯帕克兰医院投入十三亿美元用于医院整修。

10. 2016年,全球再生医药市场的业务额将达三百亿美元

据预测,和2015年相比,再生市场业务将上升22.4%,这将成为众多药物生产商的新王牌。随着该领域投资额的扩大、有利立法政策的订立以及越来越多的细胞治疗产品被推出市场,为在该领域争得一席之地,一大批新的竞争者将会涌现。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    感谢分享~~

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    感谢分享~~

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    感谢分享~~

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    不错的预测,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    不错的预测,

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2015-12-27 lsndxfj
  10. [GetPortalCommentsPageByObjectIdResponse(id=1719867, encodeId=d7721e1986732, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Thu Apr 21 06:56:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56674, encodeId=7768566e406, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56673, encodeId=c39c566e36d, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56672, encodeId=1a6f566e284, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56668, encodeId=9f41566682c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56671, encodeId=c4df566e1ae, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56670, encodeId=8c0c566e04f, content=不错的预测,, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56669, encodeId=eabd56669b6, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364080, encodeId=7cad13640801c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Dec 27 14:56:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49366, encodeId=60b549366e1, content=强, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Dec 27 13:34:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2015-12-27 cjingjuan

    0

相关资讯

Gartner预测2016十大技术趋势,3D打印和物联网将受重视

今年在Orlando召开的年度Gartner Symposium/ITxpo会议上,我们有幸窥视到了Gartner关于未来的十大战略性技术趋势预测。这些趋势预计将到2020年之前都会给企业和机构带来深刻的影响。今年的发展趋势有三大主题:The digital mesh(数字网)、smart machines(智能设备)和the new I

“科学界**巨奖”2016年度“科学突破奖”揭晓,生命科学5位科学家获奖

由俄罗斯富翁Yuri Milner领衔资助的“科学突破奖”(BREAKTHROUGH PRIZES)11月9日揭晓2016年获奖名单,此次颁发的奖项有生命科学突破奖、基础物理学突破奖、数学突破奖、物理学新视野奖、数学新视野奖以及青年挑战突破奖。“科学突破奖”单项奖金高达300万美元,远超诺贝尔奖,堪称科学界“第一巨奖”。在生命科学突破奖方面,共有5位科学家获奖,每人各获得300万美元奖金。他们分别

瞎想:2016年学术期刊出版

说是回校休假,可是一周下来,感觉比在村里还累。几天的本职工作的回归,脑子里对2016年有一些感觉,只是感觉,想留下来,所以名曰“瞎想”。 (1)学术的回归,在纷纷扬扬之后,2016年应该会走向实际,会有一些可行的路径探索,而不是一味的抱怨,也不是空泛的理想期盼。政策的矫正,从“矫枉”开始,逐步走向规范,但这种规范往往是在惩罚的作用下推进。这种学术上的理想状态与现实的竞争,将是一个长期

关于2016年度国家自然科学基金项目申请与结题等有关事项的通告

为做好2016年度国家自然科学基金项目(以下简称项目)申请和2015年应结题项目结题等工作,现将有关事项通告如下: 一、项目申请 (一)项目申请接收。 1.国家自然科学基金委员会(以下简称自然科学基金委)2016年度项目申请集中接收工作自2016年3月1日开始,3月20日16时截止(3月19-20日办公,其他法定节假日不办公)。 2.2016年度集中接收申请的项目类型包括:面上项目、重